| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |